Medically refractory epilepsy comorbid with psychogenic non-epileptic seizures and intellectual disability in a patient with balanced t(14;X) translocation: a case report

Case Presentation

A 27-year-old female patient was brought to the neurology clinic with a complex medical history marked by medically refractory epilepsy and psychogenic non-epileptic seizures (PNES). The patient’s epilepsy had been diagnosed at age 9, characterized by recurrent focal seizures that progressed to generalized seizures. Despite aggressive treatment with polytherapy of antiepileptic medications, which included carbamazepine and levetiracetam, her seizures were poorly controlled, resulting in significant impact on her quality of life.

In addition to her seizure disorders, the patient presented with intellectual disabilities, evidenced by her developmental delays. Cognitive assessments indicated an IQ score significantly below average, which corresponded to her struggles in academic and social settings. The patient’s family history was notable for a genetic predisposition to seizure disorders, with multiple relatives exhibiting similar conditions.

A karyotype analysis was performed, revealing a balanced translocation t(14;X). This genetic finding raised questions regarding its potential role in the patient’s epilepsy and intellectual disability. The translocation, while balanced, may disrupt gene functions that are crucial for neuronal development and function. Further genetic tests and counseling were provided to the family to assess potential hereditary factors.

Upon entering treatment, the patient also exhibited episodes consistent with PNES, which were characterized by movements and behaviors mimicking seizures but without accompanying electrical discharges in the brain as measured by electroencephalography (EEG). These episodes contributed significantly to the overall complexity of her clinical presentation, leading to hospitalization for thorough evaluation and multidisciplinary management.

During her hospital stay, several diagnostic tests, including continuous EEG monitoring, were conducted. This approach allowed for differentiation between true epileptic seizures and PNES, a crucial step for establishing a proper treatment plan. Additionally, a psychological assessment was integrated into her care, culminating in a diagnosis of PNES in tandem with the poorly controlled epilepsy.

Her case exemplifies the intricate interplay between genetic factors, neurological conditions, and psychological aspects, highlighting the essential nature of a comprehensive approach to treatment and management. This patient’s journey underscores the necessity for ongoing research and collaborative efforts across various medical disciplines to enhance understanding and care for individuals with similar complexities.

Diagnostic Challenges

The diagnostic journey for this patient presented a range of complexities, primarily stemming from the overlap between her epilepsy and psychogenic non-epileptic seizures (PNES). Distinguishing between true epileptic seizures and PNES is crucial yet challenging, as both conditions can manifest with similar clinical features. Misdiagnosis can lead to inappropriate treatment protocols, significantly impacting patient outcomes.

Continuous EEG monitoring was instrumental in the diagnostic differentiation process. During these assessments, the presence or absence of seizure-related electrical activity could be scrutinized in real-time. In the patient’s case, EEG recordings during her episodes revealed no significant epileptiform discharges, aligning with the characteristics of PNES. Such findings suggested that the movements and behaviors observed were not due to abnormal electrical firing in the brain, but rather psychological factors. Furthermore, the presence of pronounced psychological distress alongside demonstrated lack of seizure activity in EEG provided substantial evidence pointing towards a diagnosis of PNES.

This diagnostic challenge was compounded by the patient’s intellectual disability. The cognitive difficulties could obscure the reporting of seizure experiences, raising concerns that her accounts might have been misinterpreted or downplayed. Assessments by clinical psychologists were essential here; they provided insights into her psychological state and assessed her seizure-like activities in the context of mental health, ensuring that the full spectrum of her symptoms was recognized and addressed.

Moreover, the presence of the balanced t(14;X) translocation added another layer of complexity to her case. Although this chromosomal alteration is not inherently indicative of a specific syndrome, its potential influence on neurodevelopment and seizure susceptibility warranted extensive review. Genetic counseling became a necessary component of her diagnostic process, both to understand the implications for her health and to consider the hereditary nature of her conditions. Family history provided context, with relatives exhibiting similar symptoms, emphasizing the need to evaluate genetic factors as part of the overall assessment.

Furthermore, the episodic nature of her PNES, triggered by psychological stressors that often accompanied her living circumstances, highlighted how external factors could complicate the diagnostic picture. Understanding the psychosocial triggers necessitated an exploration of her environment, past trauma, and current life stressors, which required interdisciplinary collaboration among neurologists, psychologists, and geneticists to formulate a comprehensive diagnostic strategy.

This confluence of factors—the dual seizure disorders, cognitive impairment, and genetic background—exemplifies the necessity of a multifaceted approach to diagnosis in complex cases like this one. Each layer of complexity served to reinforce the importance of meticulous evaluation and the collaboration between various specialties in confirming the diagnosis and forming an appropriate management plan tailored to the patient’s needs.

Treatment Approaches

The treatment of the patient was approached from multiple angles, addressing her medically refractory epilepsy, psychogenic non-epileptic seizures (PNES), and associated intellectual disability. Given the multifaceted nature of her condition, a collaborative multidisciplinary team was essential, which included neurologists, psychiatrists, psychologists, and genetic counselors. This integrated care model aimed to optimize her treatment plan while catering to her complex medical needs.

For her epilepsy, the treatment regimen initially consisted of a combination of standardized antiepileptic drugs (AEDs), specifically carbamazepine and levetiracetam. Despite the use of polytherapy, the patient’s seizures remained poorly controlled, necessitating a tailored approach that focused on efficacy and managing side effects. It was determined that the current pharmacological strategy required reassessment, with the consideration of alternative medications, including lamotrigine or phenytoin. The goal was to find a therapeutic option that offered better seizure control while minimizing cognitive impairment, which was critical given her pre-existing intellectual disability.

Furthermore, the patient was enrolled in a structured epilepsy monitoring program to track her seizure frequency and identify potential triggers. This included lifestyle modifications, such as maintaining a regular sleep schedule, minimizing stress, and avoiding known seizure triggers, to enhance her overall well-being. Education and support for her family were also integral components of her care, equipping them with knowledge about her conditions and effective strategies to assist in her management.

In parallel, the diagnosis of PNES required a distinct treatment strategy focused primarily on psychological intervention. Cognitive-behavioral therapy (CBT) was implemented, aiming to help her develop coping mechanisms to address the stressors triggering her PNES. This therapy incorporated psychoeducation to educate her about the nature of her condition, thereby reducing the stigma and misunderstanding surrounding her symptoms. Sessions were designed to enhance her emotional awareness and skills to self-manage her responses to psychological stress, which could lead to a reduction in seizure-like episodes.

Additionally, the integration of psychiatric support was paramount. The patient underwent a thorough psychological assessment to evaluate her emotional state and identify any underlying mental health issues, such as anxiety or depression, which could exacerbate her PNES. Adjustments to her treatment regimen were made based on the results of these assessments, emphasizing the importance of treating the psychological aspects of her condition in conjunction with her neurological challenges.

Table 1 summarizes the different treatment modalities being implemented:

Ultimately, the treatment approach for this patient necessitated continual assessment and adjustment to therapy based on response and overall progress. The multidisciplinary team remained vigilant in evaluating her condition, fostering an iterative process that would adapt to her evolving needs. This holistic strategy aimed to improve not only her seizure control but also her quality of life, which was profoundly affected by the interplay of her neurological and psychological conditions.

Future Directions

The future management of this patient’s complex medical presentation necessitates an ongoing commitment to personalized and dynamic treatment strategies. Given the multifaceted interactions between her epilepsy, PNES, intellectual disability, and the genetic implications from the t(14;X) translocation, several forward-looking directions for care and research can be anticipated.

Firstly, advancements in genetic research present an opportunity to investigate the implications of the balanced chromosomal translocation further. Understanding whether this genetic alteration correlates with particular phenotypes or treatment responses could lead to tailored interventions for similar patients. Future genetic studies may include whole-exome sequencing or focused gene panels to identify candidate genes that might be disrupted by the translocation. Such findings may illustrate the biological underpinnings of seizure disorders and cognitive impairments, allowing for personalized genetic counseling and targeted therapies.

Secondly, improving the diagnostic process through developments in neuroimaging and EEG technology is essential. Functional neuroimaging techniques, such as fMRI or PET scans, could enhance the understanding of brain activity and connectivity patterns in individuals with both epilepsy and PNES. This could facilitate distinguishing between seizure types more effectively, ultimately refining treatment protocols. Enhanced EEG methodologies, including advanced event-related potentials and high-density electrode arrays, could provide more precise evaluations of brain activity during episodes, helping to mitigate diagnostic uncertainties.

Next, the importance of comprehensive psychological care cannot be overstated. Increasing emphasis on integrated models of care that include coordinations between neurologists and mental health professionals will foster holistic treatment approaches. Future initiatives might focus on developing standardized protocols for managing PNES alongside medical seizure disorders, ensuring that both components are addressed concurrently rather than sequentially. Moreover, expanding access to cognitive-behavioral therapies could provide a more significant societal benefit, as evidence suggests that early psychological intervention leads to improved outcomes.

Moreover, there may be potential for employing emerging treatments or therapies, such as neuromodulation techniques like transcranial magnetic stimulation (TMS) or responsive neurostimulation (RNS). Research into the efficacy of these treatments for refractory cases of epilepsy and PNES could offer new therapeutic avenues, particularly for patients that do not respond well to conventional therapies. Studies evaluating the long-term benefits and safety profiles of such interventions could significantly influence future practice.

Lastly, there must be continuous exploration into the psychosocial aspects affecting patients with dual diagnoses. Addressing social determinants of health, providing community resources, and fostering environments conducive to mental well-being can profoundly impact outcome measures for patients. Future studies could evaluate the efficacy of community-based supports and educational initiatives aimed at enhancing social and academic skills for patients with epilepsy and intellectual disabilities.

Table 1 outlines the prospective future directions for research and treatment:

Through these initiatives, ongoing research, and collaborative care models, the aim would be not only to improve clinical outcomes but also to enhance the overall well-being of patients facing the compounded difficulties associated with medically refractory epilepsy, PNES, and intellectual disabilities.